http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102603621-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f1cc134e139490e374ccf80c05d94857
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-68
filingDate 2012-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8b4e57373bfe45f568c3bb5f00f94ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24ee37fa5b755ef36d543a418ea856ff
publicationDate 2012-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102603621-A
titleOfInvention A kind of novel chiral sulfoxide compound and the method for preparing esomeprazole sodium with this compound
abstract The invention discloses a (S)-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl) ethyl thioformate compound and its preparation method and The technology of preparing esomeprazole sodium with this compound, the remarkable advantage of the present invention is, synthetic raw material is cheap and easy to get, and reaction condition is gentle, the yield of preparation esomeprazole sodium salt is high, optical purity is high, safe to operate, to The environmental pollution is small, and it is more suitable for industrialized large-scale production.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104098516-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104098515-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104098515-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104557867-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104098516-A
priorityDate 2012-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010134099-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6245913-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008152462-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1085019-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163647267
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID153404
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465427559
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414939228
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163545352
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465134048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID149462464
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416016938
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID572659
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163750253
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420982982
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465279489

Total number of triples: 33.